If there are no GI symptoms but the drug was not DCd as suggested, treat as full stomach, evaluate contents with ultrasound, and consider delaying the procedure
Nakatani Y, Maeda M, Matsumura M, Shimizu R, Banba N, Aso Y, et al
Compare and contrast the glucagon-like peptide-1 receptor agonists (GLP1RAs) [Updated 2024 Feb 25]
"Those products, the GLP-1 patches and drops, they're just trying to join the enthusiasm and kind of, I would say, madness, surrounding these medications that certainly can enhance weight reduction and can improve blood sugar control in diabetes," Dasgupta said from Halifax
Whether the right answer turns out to be a dose pause, a slower titration, supportive medication, a switch between Wegovy and Zepbound, or a different approach, we want to be in the conversation when that decision is made
The neuroprotective effect of exendin-4 was found to be independent of the glucose-increasing effect, whereas related to increasing the levels of cAMP and reducing oxidative stress and the inflammatory response (83)
